论文信息 - Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient Treated with a Novel Combination Treatment with Anti PDL1 Antibody (Durvalumab) and VEGFR2 Antibody (Ramucirumab) - 字舞流文

Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient Treated with a Novel Combination Treatment with Anti PDL1 Antibody (Durvalumab) and VEGFR2 Antibody (Ramucirumab)

J. García-Foncillas | V. Moreno | A. Rupérez | B. Doger | R. Hernández | T. Hernández | J. R. Pérez | Yolanda Lage | E. Ruiz | T. Hernandez